Search Results

Polarean, a commercial-stage medical device leader in advanced magnetic resonance imaging of the lungs, announced it has partnered with VIDA Diagnostics, a clinical imaging intelligence company providing medical imaging software solutions which manage the complexities of digital biomarkers.

VIDA Diagnostics, Inc. (VIDA), the leader in imaging intelligence, has announced the availability of VIDA Intelligence Portal 2.0, a major upgrade of its cloud native, AI-enabled Intelligence platform.

CUTERA, INC., a leading provider of aesthetic and dermatology solutions, announced that it has entered into cooperation agreements with two of its largest stockholders, Pura Vida Investments, LLC and RTW Investments, LP, which collectively own more than 15% of the Company’s outstanding shares.

VIDA Diagnostics, Inc. (VIDA), the leader in imaging intelligence, has partnered with Wellspring Capital-backed RAYUS Radiology, a leading national provider of advanced diagnostic and interventional radiology, to onboard more than 150 locations as clinical trial imaging sites

Ending the diagnostic journey for patients, particularly those with rare diseases, improves patients’ quality of life while reducing costs to healthcare systems.

VIDA Diagnostics, Inc., the leader in lung and respiratory intelligence, announced it has secured financing as it scales up to support strong demand for its VIDA Intelligence Portal, an AI-powered solution that supports clinical trial decentralization and improves site recruitment, onboarding, staff training, image data management and data quality.

VIDA Diagnostics, Inc., the leader in lung and respiratory intelligence data, is introducing a new suite of retrospective data analysis services for clinical trial sponsors in response to growing demand for precision data to optimize lung treatment trials.

VIDA Diagnostics, Inc. (VIDA) is further removing friction in respiratory clinical trials with the introduction of a new AI-powered portal.